688276.SS
Price:
$20.86
Market Cap:
$5.05B
Changchun BCHT Biotechnology Co. Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of human vaccines in China and internationally. Its products include live herpes zoster vaccine; live varicella vaccine; live, nasal, and freeze-dried influenza vaccine; and Rabies vaccine (vero cell) for humans. The company was founded in 2004 and is based in Changchun, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-06-25
Stock Exchange
SHH
Ticker
688276.SS
According to Changchun BCHT Biotechnology Co.’s latest financial reports and current stock price. The company's current PE Ratio is 50.88. This represents a change of -89.81% compared to the average of 499.34 of the last 4 quarters.
The mean historical PE Ratio of Changchun BCHT Biotechnology Co. over the last ten years is 185.78. The current 50.88 PE Ratio has changed 2.64% with respect to the historical average. Over the past ten years (40 quarters), 688276.SS's PE Ratio was at its highest in in the March 2025 quarter at 2.14K. The PE Ratio was at its lowest in in the December 2022 quarter at -235.53.
Average
185.78
Median
137.07
Minimum
44.73
Maximum
455.77
Discovering the peaks and valleys of Changchun BCHT Biotechnology Co. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.16%
Maximum Annual PE Ratio = 455.77
Minimum Annual Increase = -71.54%
Minimum Annual PE Ratio = 44.73
Year | PE Ratio | Change |
---|---|---|
2024 | 44.84 | 0.25% |
2023 | 44.73 | -71.54% |
2022 | 157.17 | 35.16% |
2021 | 116.28 | -0.59% |
2020 | 116.97 | -47.15% |
2019 | 221.34 | -32.76% |
2018 | 329.17 | -27.78% |
The current PE Ratio of Changchun BCHT Biotechnology Co. (688276.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
82.24
5-year avg
96.00
10-year avg
185.78
Changchun BCHT Biotechnology Co.’s PE Ratio is greater than CanSino Biologics Inc. (-64.61), greater than Shanghai Junshi Biosciences Co., Ltd. (-23.03), greater than Pylon Technologies Co., Ltd. (-9931.68), greater than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (32.98), greater than Betta Pharmaceuticals Co., Ltd. (50.53),
Company | PE Ratio | Market cap |
---|---|---|
-64.61 | $8.98B | |
-23.03 | $25.48B | |
-9931.68 | $10.63B | |
32.98 | $10.39B | |
50.53 | $20.51B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Changchun BCHT Biotechnology Co. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Changchun BCHT Biotechnology Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Changchun BCHT Biotechnology Co.'s PE Ratio?
How is the PE Ratio calculated for Changchun BCHT Biotechnology Co. (688276.SS)?
What is the highest PE Ratio for Changchun BCHT Biotechnology Co. (688276.SS)?
What is the 3-year average PE Ratio for Changchun BCHT Biotechnology Co. (688276.SS)?
What is the 5-year average PE Ratio for Changchun BCHT Biotechnology Co. (688276.SS)?
How does the current PE Ratio for Changchun BCHT Biotechnology Co. (688276.SS) compare to its historical average?